Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Idenix Pharmaceuticals Articles

New briefs on Pfizer interest in Protalix; Novo Nordisk warning letter; Hemispherx' Ampligen; and Idenix' hep C program

6 February 2013

Idenix plunges as FDA puts clinical hold on hepatitis C drug candidate

17 August 2012

Novartis restructures deal with Idenix Pharmaceuticals

1 August 2012

News of clinical hold on AIDS drug sees Idenix Pharma shares plunge 25%

10 February 2011

Idenix Pharma slumps as US FDA puts “clinical hold” on two of the firm’s hepatitis C programs

8 September 2010

Showing 1-5 of 5 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS